Cassava Sciences Stock (NASDAQ: SAVA) stock price, news, charts, stock research, profile.
You can purchase shares of Cassava Sciences (NASDAQ:SAVA) through any online brokerage.
Other companies in Cassava Sciences’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS) and Phibro Animal Health (NASDAQ:PAHC).
Cassava Sciences has a consensus price target of $75.50.
The stock price for Cassava Sciences (NASDAQ: SAVA) is $29.2 last updated September 24, 2024 at 7:59 PM EDT.
A quarterly cash dividend of 0.75 per share of Class A Common Stock. The quarterly cash dividend was payable on December 24, 2012 to stockholders of record on December 13, 2012.
Cassava Sciences’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Cassava Sciences.
Cassava Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.